Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$3.27 - $9.48 $302,599 - $877,260
-92,538 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$7.71 - $10.79 $57,532 - $80,514
-7,462 Reduced 7.46%
92,538 $835,000
Q2 2020

Aug 13, 2020

BUY
$9.0 - $13.12 $900,000 - $1.31 Million
100,000 New
100,000 $900,000

Others Institutions Holding BIOR

About BIORA THERAPEUTICS, INC.


  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $41.1M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.